{'fraction_non_alphanumeric': 0.01845444059976932, 'fraction_numerical': 0.0, 'mean_word_length': 5.382352941176471, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Influence of hypertension on lower urinary tract symptoms in benign prostatic hyperplasia

The previous article provided a very interesting evaluation of the effects of an α -blocker on lower urinary tract symptom scores in hypertensive (HT) and normotensive (NT) benign prostatic hyperplasia patients. Circulating catecholamines seem to have a beneficial effect on filling symptoms like frequency and nocturia, which may be partly induced by HT. However, voiding symptoms such as weak stream and hesitancy, which may be poorly related to hypertension, respond to the drug (the drug has a better effect in NT than HT). This suggests a relation between BPE and BOO and indicates the need for studies of the possible correlation between the grade of enlargement and voiding symptoms, taking into consideration the physiopathological mechanism of functional obstruction.